The Fund Grade · free · no account needed

What grade does PBFDX get?

Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.

A

Fundprints Fund Grade · as of 2026-09-01

Payson Total Return Fund

#37 of 440 graded active funds · blend · large segment peer group

The point · specialist footprint

PBFDX puts more of its book behind proven specialists than 95% of graded funds.

Bottom 20%

Bottom 40%

Middle

Top 40%

● Top 20%

beat the S&P in 22% of quarters+3.8 pts/qtr better · 43% beat rate

That has mattered: over the past 2.7 years, funds on this rung beat bottom-rung funds by about 3.8 points per quarter, and beat the S&P in 43% of fund-quarters versus their 22%. The evidence argues this fund earns its seat.

2,825 graded funds · 2.7 years of filings, measured as they were published · evidence, not advice

The grade scores this fund's specialist share — the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.

Conviction exposure

51.3%

of the book in specialist-converged names

Late-stage weight

17.9%

of the book in Crowded or Fading names

Active share

82.7%

how far it strays from the index

The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.

Inside the book — top names by stage · as of 2026-09-09

Early Conviction
AMZN 5.5%ASML 3.5%
Consensus
NVDA 8.6%MSFT 7.8%META 4.6%+9 locked
Emerging
HUBB 2.1%DHR 0.9%ACN 0.8%
Fading
AVGO 6.1%HON 2.9%TJX 2.3%+2 locked

We email you the day it crosses 50% crowded, and where you stand every month.

Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.

The read · what to do with it

Payson Total Return Fund earns an A grade and ranks 37th out of 440 graded funds, with specialists backing over half the portfolio. The most striking detail is its early conviction in NVDA at 8.6% and AMZN at 5.5%, while META at 4.6% is the largest position where specialists are actively leaving.

Watch META closely: at 4.6% it is the fund's biggest fading position and specialist exits there warrant monitoring.

The NVDA and AMZN early conviction weighting argues this fund is genuinely ahead of consensus in its two largest growth bets.

Support leaving these positions

AVGO 6.1% of the fund · Fading

HON 2.9% of the fund · Fading

TJX 2.3% of the fund · Fading

AZO 2.1% of the fund · Fading

LHX 1.5% of the fund · Fading

Where it's genuinely early

AMZN 5.5% of the fund · Early Conviction

ASML 3.5% of the fund · Early Conviction

HUBB 2.1% of the fund · Emerging

Read from today's disclosed book. Evidence, not advice.

The evidence base updates this week.

The specialists — not the whales — are already positioned for what comes next. Stop finding out last.

Create your free account

No card required · open the feed in 30 seconds